(1) TORONTO, ON / ACCESSWIRE / March 2, 2021 / Sparta Group (TSXV:SAY) (the "Corporation" the "Company", "Sparta Group", "Sparta Capital", "SAY.V" or "Sparta") has signed a Memorandum of Understanding ("MOU") with Ethema Health Corporation (GRST) of West Palm Beach, FL ("Ethema") that could see the Company expand business into new markets related to the fight against emerging pathogens, including SARS-CoV-2, the virus responsible for the COVID-19 pandemic. For over 40 years, the food processing industry has been expanding technology to include various forms of pathogen killing processing equipment. Much of the continuous pathogen protection revolves around the use of a naturally occurring substance known as hypochlorous acid ("HOCl"), which both beef and poultry processors have discovered is effective, affordable, and safe to use. With a number of COVID-19 variants circulating the globe and some experts talking about a third wave to the pandemic, the two joint venture partners have decided to explore the use of HOCl disinfectant technologies in various market verticals, including health-related and industrial manufacturing settings.